IP Verse

Method For Treating Primary Insomnia

Patent No. EP3103443 (titled "Method For Treating Primary Insomnia") was filed by Neurim Pharmaceuticals on Aug 12, 2002. The application was issued on Jun 30, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MAIWALDMar 29, 2022MAIWALD
NEURAXPHARM ARZNEIMITTELMar 29, 2022TER MEER STEINMEISTER & PARTNER
TEVA PHARMACEUTICALSMar 29, 2022ELKINGTON AND FIFE
HAMM & WITTKOPPFeb 9, 2022HAMM & WITTKOPP
ORIFARM GENERICSSep 30, 2021ZBM PATENTS APS
GENERICS UKJun 30, 2021ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3103443

NEURIM PHARMACEUTICALS
Application Number
EP16172415A
Filing Date
Aug 12, 2002
Status
Granted And Under Opposition
May 28, 2021
Publication Date
Jun 30, 2021
External Links
Slate, Register , Google Patents